Table 1.
Subject Characteristics. Data represented as mean (SD).
| HO | PD | p-values | |
|---|---|---|---|
| N (#female) | 12 (6) | 15 (3) | 0.13* |
| Age | 68.04 (6.61) | 66.34 (6.02) | 0.49α |
| MoCA | 27.17 (1.64) | 27.2 (3.0) | 0.97α |
| MiniBEST | 25.25 (2.18) | 23.2 (3.8) | 0.11α |
| Years with Disease | -- | 6.38 (4.75) | -- |
| UPDRS-III | -- | 25.4 (13.8) | -- |
| Hoehn & Yahr Stage | -- | 2.00 (0.38) | -- |
| Levodopa Dosage | -- | 598.67 (228.41) | -- |
*
Fisher’s Exact Test;
α
Independent Samples T-test
Abbreviations: HO- Healthy older adults; PD- Parkinson’s disease; UPDRS-III- Unified Parkinson’s Disease Rating Scale- Part III (motor) score; MiniBEST- Mini Balance Evaluation System Test; MoCA- Montreal Cognitive Assessment; COM- Center of Mass; PD- Parkinson’s disease; HO- Healthy older adult;